Advertisement
UK markets close in 2 hours 34 minutes
  • FTSE 100

    8,178.34
    +31.31 (+0.38%)
     
  • FTSE 250

    20,043.59
    -41.20 (-0.21%)
     
  • AIM

    763.96
    +0.63 (+0.08%)
     
  • GBP/EUR

    1.1690
    -0.0022 (-0.19%)
     
  • GBP/USD

    1.2514
    -0.0048 (-0.38%)
     
  • Bitcoin GBP

    50,119.69
    -539.11 (-1.06%)
     
  • CMC Crypto 200

    1,273.52
    -65.54 (-4.89%)
     
  • S&P 500

    5,116.17
    +16.21 (+0.32%)
     
  • DOW

    38,386.09
    +146.43 (+0.38%)
     
  • CRUDE OIL

    83.16
    +0.53 (+0.64%)
     
  • GOLD FUTURES

    2,320.40
    -37.30 (-1.58%)
     
  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • DAX

    17,994.74
    -123.58 (-0.68%)
     
  • CAC 40

    8,031.78
    -33.37 (-0.41%)
     

How CareDx (CDNA) Stock Stands Out in a Strong Industry

One stock that might be an intriguing choice for investors right now is CareDx, Inc CDNA. This is because this security in the Medical Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical Services space as it currently has a Zacks Industry Rank of 53 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, CareDx is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past two months, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

CareDx, Inc. Price and Consensus

CareDx, Inc. Price and Consensus
CareDx, Inc. Price and Consensus

CareDx, Inc. price-consensus-chart | CareDx, Inc. Quote

ADVERTISEMENT

In fact, over the past two months, current quarter estimates have narrowed from a loss of 20 cents per share to a loss of 19 cents per share, while current year estimates have narrowed from a loss of 73 cents per share to a loss of 57 cents per share. The company currently carries a Zacks Rank #3 (Hold), which is also a favorable signal. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider CareDx. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CareDx, Inc. (CDNA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research